Conference CME Symposia

October 14-17, 2021

16th Annual Cardiometabolic Health Congress

Gaylord National Resort
201 Waterfront Street
National Harbor, MD 20745

2021 Annual CME Symposia

Round out your educational experience by attending Professional Medical Education/Product Theater symposia focused on novel therapies. These non-certified activities are planned solely by the sponsoring organizations and companies.

Chaired by:
Gregory A. Poland, MD

Thursday, October 14, 2021
1:15 – 2:15 PM ET

Primetime CME Symposium

Prevention and Treatment of Influenza in High-Risk Patients with Cardiometabolic Comorbidities: Interpreting the Evidence to Decrease the Risk of Complications

Sponsored by: This activity is jointly provided by Postgraduate Institute for Medicine and CMHC. Supported by an educational grant from Genentech, a member of the Roche Group.

Learning Objectives:

After completing this activity, the participant should be better able to:

  • Review the influenza life cycle and the clinical impacts of influenza in patients with chronic cardiometabolic conditions
  • Summarize influenza vaccine recommendations and the efficacy and safety of influenza vaccines in high-risk patients
  • List practical steps and strategies to increase influenza immunization in high-risk cardiometabolic patients
  • Interpret existing and new evidence with traditional and new influenza treatments for high-risk patients, including differences in efficacy, safety, and mechanisms of action
  • Utilize approaches to reducing the burden of influenza in cardiometabolic patients, including prompt treatment with antivirals or referrals.
Cmhc Logo Color Lg
Postgraduate Institute For Medicine Logo

This activity is approved for AMA PRA Category 1 Credits. This activity is eligible for ABIM MOC, ACPE, ANCC and CDR credit, see final activity announcement for specific details. Full CME information to come.

Chaired by:
Harold E. Bays, MD

Friday, October 15, 2021
10:45 – 11:45 AM ET

Primetime CME Symposium

Challenges and Advances in Long-Term Obesity Management: Interpreting and Applying the Evidence to Patient Care

Sponsored by: This activity is jointly provided by Postgraduate Institute for Medicine and CMHC. Supported by an educational grant from Novo Nordisk.

Learning Objectives:
After completing this activity, the participant should be better able to:
  • Identify obesity as a treatable disease and incorporate practical approaches for its screening and diagnosis.
  • Review the efficacy and safety of obesity pharmacotherapy in the treatment of patients with obesity.
  • Recommend comprehensive treatment strategies, including lifestyle modification and obesity pharmacotherapy, to address overweight and obesity and lower cardiometabolic risk.
Cmhc Logo Color Lg
Postgraduate Institute For Medicine Logo

This activity is approved for AMA PRA Category 1 Credits. This activity is eligible for ABIM MOC, ACPE, ANCC and CDR credit, see final activity announcement for specific details. Full CME information to come.

Chaired by:
Vanita R. Aroda, MD

Saturday, October 16, 2021
3:00 – 4:00 PM ET

Primetime CME Symposium

Reducing Cardiovascular Risk with GLP-1 RAs in Diabetes Patients: Evolving Concepts and Paradigm Shifts

Sponsored by: This activity is jointly provided by Postgraduate Institute for Medicine and CMHC. Supported by an educational grant from Novo Nordisk.

Learning Objectives:
After completing this activity, the participant should be better able to:

  • Summarize the mechanisms of action, different properties, as well as efficacy and safety of GLP-1 RAs, alone or in combination, for the management of T2DM.
  • Interpret the current evidence from CVOTs and real-world studies with GLP-1 RAs and their practice implications in managing T2DM patients with CVD or at CVD risk.
  • Review the recent guideline updates about the individualization of T2DM therapy in patients with existing CVD or CVD risk.
  • Develop individualized treatment strategies for patients with T2DM that optimize glycemic control and reduce overall CVD risk.
Cmhc Logo Color Lg
Postgraduate Institute For Medicine Logo

This activity is approved for AMA PRA Category 1 Credits. This activity is eligible for ABIM MOC, ACPE, ANCC and CDR credit, see final activity announcement for specific details. Full CME information to come.

Chaired by:
George L. Bakris, MD

Sunday, October 17, 2021
8:35 – 9:35 AM ET

Primetime CME Symposium

Challenges and Advances in Diabetic Kidney Disease: Tackling the Drivers of CKD Progression in T2DM

Sponsored by: This activity is jointly provided by Postgraduate Institute for Medicine and CMHC. Supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.

Learning Objectives:

After completing this activity, the participant should be better able to: 

  • Identify T2DM patients at risk for kidney disease or kidney disease progression.
  • Develop appropriate treatment options for patients with DKD based on current guideline recommendations and available treatment options.
  • Summarize the efficacy, safety, and mechanisms of action of emerging treatment options for DKD.
Cmhc Logo Color Lg
Postgraduate Institute For Medicine Logo

This activity is approved for AMA PRA Category 1 Credits. This activity is eligible for ABIM MOC, ACPE, ANCC and CDR credit, see final activity announcement for specific details. Full CME information to come.

Conference Venue

Join us at the Gaylord National Resort

After an unexpected year filled with numerous changes, and a significant decrease in in-person interaction, the value and importance of building connections in-person is more evident than ever. Join CMHC just outside Washington, D.C. at the Gaylord National Resort in National Harbor to connect with like-minded peers and industry leaders.

Conference Venue

Gaylord National Resort

201 Waterfront Street
National Harbor, MD 20745

Room Rate: $265
Expires: 9-23-2021
Room Reservation Phone: 1 (888) 789-3090

CMHC Sponsors & Partners

Join this year’s illustrious lineup of brand partners and take your 2021 goals to next level.